147 related articles for article (PubMed ID: 20695463)
1. Transnasal delivery of methotrexate to brain tumors in rats: a new strategy for brain tumor chemotherapy.
Shingaki T; Inoue D; Furubayashi T; Sakane T; Katsumi H; Yamamoto A; Yamashita S
Mol Pharm; 2010 Oct; 7(5):1561-8. PubMed ID: 20695463
[TBL] [Abstract][Full Text] [Related]
2. In vivo microdialysis to characterize drug transport in brain tumors: analysis of methotrexate uptake in rat glioma-2 (RG-2)-bearing rats.
Devineni D; Klein-Szanto A; Gallo JM
Cancer Chemother Pharmacol; 1996; 38(6):499-507. PubMed ID: 8823490
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE
Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031
[TBL] [Abstract][Full Text] [Related]
4. [Local chemotherapy for malignant brain tumors using methotrexate-containing fibrin glue].
Hirakawa W; Kadota K; Asakura T; Niiro M; Yokoyama S; Hirano H; Yatsushiro K; Kubota Y; Shimodozono Y
Gan To Kagaku Ryoho; 1995 May; 22(6):805-9. PubMed ID: 7755389
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability.
Dhanikula RS; Argaw A; Bouchard JF; Hildgen P
Mol Pharm; 2008; 5(1):105-16. PubMed ID: 18171013
[TBL] [Abstract][Full Text] [Related]
6. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
[TBL] [Abstract][Full Text] [Related]
8. [Histopathological and autoradiographical studies of experimental brain tumors after continuous local chemotherapy--acute stage in rat models].
Shimura T; Teramoto A; Aihara K
Gan To Kagaku Ryoho; 1997 Apr; 24(6):713-8. PubMed ID: 9126309
[TBL] [Abstract][Full Text] [Related]
9. Profiles of methotrexate in blood and CSF following intranasal and intravenous administration to rats.
Wang F; Jiang X; Lu W
Int J Pharm; 2003 Sep; 263(1-2):1-7. PubMed ID: 12954175
[TBL] [Abstract][Full Text] [Related]
10. Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries.
Erdlenbruch B; Alipour M; Fricker G; Miller DS; Kugler W; Eibl H; Lakomek M
Br J Pharmacol; 2003 Dec; 140(7):1201-10. PubMed ID: 14597599
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of methotrexate in plasma and cerebrospinal fluid.
Morikawa N; Mori T; Abe T; Ghoda M; Takeyama M; Hori S
Ann Pharmacother; 1997 Oct; 31(10):1153-6. PubMed ID: 9337440
[TBL] [Abstract][Full Text] [Related]
12. Transnasal delivery of 5-fluorouracil to the brain in the rat.
Sakane T; Yamashita S; Yata N; Sezaki H
J Drug Target; 1999; 7(3):233-40. PubMed ID: 10680979
[TBL] [Abstract][Full Text] [Related]
13. Growth of human lung tumor in the brain of the nude rat as a model to evaluate antitumor agent delivery across the blood-brain barrier.
Neuwelt EA; Frenkel EP; D'Agostino AN; Carney DN; Minna JD; Barnett PA; McCormick CI
Cancer Res; 1985 Jun; 45(6):2827-33. PubMed ID: 2985254
[TBL] [Abstract][Full Text] [Related]
14. High-dose methotrexate with citrovorum factor rescue for the treatment of central nervous system tumors in children.
Rosen G; Ghavimi F; Nirenberg A; Mosende C; Mehta BM
Cancer Treat Rep; 1977 Jul; 61(4):681-90. PubMed ID: 301781
[TBL] [Abstract][Full Text] [Related]
15. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.
Ying X; Wen H; Lu WL; Du J; Guo J; Tian W; Men Y; Zhang Y; Li RJ; Yang TY; Shang DW; Lou JN; Zhang LR; Zhang Q
J Control Release; 2010 Jan; 141(2):183-92. PubMed ID: 19799948
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy for experimental subarachnoid dissemination model of brain tumor].
Yamashita T; Shinonaga M; Ishiwata Y; Nishimura S; Murai M; Kyuma Y; Kuwabara T
No Shinkei Geka; 1984 Jan; 12(1):47-53. PubMed ID: 6585681
[TBL] [Abstract][Full Text] [Related]
17. Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors.
Neuwelt EA; Rapoport SI
Fed Proc; 1984 Feb; 43(2):214-9. PubMed ID: 6692941
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic efficacy of intracarotid infusion of 20% mannitol with ACNU in Fischer rats with intracerebrally implanted 9L gliosarcoma].
Miyagami M; Tazoe M; Kasahara E; Tsubokawa T
Gan To Kagaku Ryoho; 1989 May; 16(5):2059-65. PubMed ID: 2499268
[TBL] [Abstract][Full Text] [Related]
19. Effects of leucovorin (folinic acid) in the methotrexate-treated rat brain.
Ogushi N; Sasaki K; Shimoda M
J Vet Med Sci; 2018 May; 80(5):760-765. PubMed ID: 29607891
[TBL] [Abstract][Full Text] [Related]
20. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats.
Erdlenbruch B; Jendrossek V; Kugler W; Eibl H; Lakomek M
Cancer Chemother Pharmacol; 2002 Oct; 50(4):299-304. PubMed ID: 12357304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
